Senti Biosciences (SNTI) EBITDA Margin (2021 - 2023)

Senti Biosciences' quarterly EBITDA Margin came in at 4415.09% in Q3 2023, down 331746.0% year-on-year from N/an in Q3 2022, and down 62.2% quarter-over-quarter from 2721.98% in Q2 2023.

Senti Biosciences has reported EBITDA Margin for 3 years, with the latest figure at 4415.09% in Q3 2023.

  • For the quarter ending Q3 2023, EBITDA Margin fell 331746.0% year-over-year to 4415.09%; the trailing twelve-month figure through Jun 2024 stood at 16850.0% (down 1465870.0% YoY), and the FY2025 full-year result was 279263.64%, changed N/A from the prior year.
  • EBITDA Margin for Q3 2023 stood at 4415.09%, down from 2721.98% in the prior quarter.
  • The five-year high for EBITDA Margin was 9533.51% in Q4 2022, with the low at 4415.09% in Q3 2023.
  • Average EBITDA Margin over 3 years is 622.15%, with a median of 1236.33% recorded in 2021.
  • Year-over-year, EBITDA Margin surged 1090854 bps in 2022 and plunged 331746 bps in 2023.
  • Tracing SNTI's EBITDA Margin over 3 years: stood at 1375.03% in 2021, then surged by 793 bps to 9533.51% in 2022, then slumped by 146 bps to 4415.09% in 2023.
  • The last three EBITDA Margin figures came in at 4415.09% (Q3 2023), 2721.98% (Q2 2023), and 1455.68% (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.35%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.24%
10 Senti Biosciences Holdings 22.25 Mn 22.25 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -4,415.09%
Jun 30, 2023 -2,721.98%
Mar 31, 2023 -1,455.68%
Dec 31, 2022 9,533.51%
Sep 30, 2022 -1,097.63%
Jun 30, 2022 -1,042.60%
Mar 31, 2022 -1,069.57%
Dec 31, 2021 -1,375.03%
Sep 30, 2021 -1,034.09%
Jun 30, 2021 -1,543.32%